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Abstract
Background
The association between metabolic syndrome (MetS) and all-cause mortality is well estab-
lished but it is unclear if there are differences in mortality risk among the 32 possible MetS
combinations. Hence, the purpose of this study is to evaluate the associations between dif-
ferent MetS combinations and its individual components with all-cause mortality, and to
examine differences in the association by age and sex.
Methods
A merged sample of 82,717 adults from 7 U.S. cohorts was used.
Results
In our sample, MetS was present in 32% of men, 34% of women, 28% of younger adults
(18–65 years) and 62% of older adults (>65 years) with 14,989 deaths over 14.6 ± 7.4 years
of follow-up. Risk of all-cause mortality was higher in younger individuals with a greater num-
ber of MetS factors present, but in older adults having all 5 MetS factors was the only combi-
nation significantly associated with mortality. Regardless of age or sex, elevated blood
pressure was the MetS factor most consistently present in MetS combinations that were sig-
nificantly and most strongly associated with mortality. In fact, elevated blood pressure in the
absence of other risk factors was significantly associated with mortality in men (HR, 95% CI
= 1.56, 1.33–1.84), women (HR = 1.62, 1.44–1.81) and younger adults (HR = 1.61, 1.45–
1.79). Conversely, waist circumference, glucose and triglycerides in isolation were not asso-
ciated with mortality (p>0.05).
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Conclusion
In a large U.S. population, different combinations of MetS components vary substantially in
their associations with all-cause mortality. Men, women and younger individuals with MetS
combinations including elevated blood pressure had stronger associations with greater mor-
tality risk, with minimal associations between MetS and mortality risk in older adults. Thus,
we suggest that future algorithms may wish to consider differential weighting of these com-
mon metabolic risk factors, particularly in younger populations.
Introduction
Metabolic syndrome (MetS) is the clustering of three or more metabolic risk factors as defined
by the revised National Cholesterol Education Program (NCEP) criteria [1]. It is well estab-
lished that individuals with MetS are at an increased risk for CVD [2–4] and all-cause mortal-
ity [5,6]. There is heterogeneity in how MetS is defined [7,8] as well as potential sex and age
differences in the way metabolic factor combinations are related with mortality risk [9]. To
our knowledge, studies that previously identified MetS combinations and their associations
with mortality risks had short follow-up time [10] and low incident all-cause mortality associ-
ated with each MetS cluster [11]. Thus, few studies have a large enough sample size to catego-
rize participants into each of the 32 MetS combinations and examine the specific mortality
risk associated with each combination separately [9]. Hence, the objective of this study is to
determine whether different MetS combinations vary in their associations with all-cause mor-
tality and to determine whether there are differences by age and sex.
Methods
Study population
Seven U.S. population cohorts were merged to form the study sample including the Aerobics
Center Longitudinal Study (ACLS) [12], Atherosclerosis Risk in Communities Study (ARIC)
[13], Coronary Artery Risk Development in Young Adults (CARDIA) [14], Cardiovascular
Health Study (CHS) [15], Multi-Ethnic Study of Atherosclerosis (MESA) [16], Third National
Health and Nutrition Examination Survey (NHANES III) [17,18], and the Continuous
NHANES (1999–2008) [19,20]. All study participants provided written informed consent for
their respective studies. Complete details of individual study designs, procedures, laboratory
measurements clinical examinations and analytic guidelines have been previously reported
elsewhere.
Participants were excluded if they had missing information on any of the metabolic risk fac-
tor (n = 11,640), age> 90 (n = 10) or had missing mortality follow-up data (n = 246). Partici-
pants with missing SBP (n = 207), fasting serum triglycerides >10 mmol/L (n = 104), fasting
plasma glucose>30 mmol/L (n = 14) and HDL cholesterol >5 mmol/L (n = 3) were also
excluded. The final sample included 82,717 participants.
Limited data access for ARIC, CARDIA, CHS and MESA was obtained through the
National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH).
This manuscript was prepared using research materials obtained from the NHLBI Data Repos-
itory Information Coordinating Center and does not necessarily reflect the opinions or views
of the study survey investigators or the NHLBI. NHANES III and Continuous are available
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publicly online. Institutional ethics approval to analyze this merged dataset was obtained from
York University’s Research Ethics Board (e2013–286 & e2017–364).
Datasets
Aerobics Center Longitudinal Study (ACLS)–these analyses included 37,691 participants
over 18 years of age from the original cohort who attended the Cooper Clinic (Dallas, TX) for
periodic self- or physician-referred medical examinations between 1987 and 2001. Mortality
follow-up to December 31, 2003 was used.
Atherosclerosis Risk in Communities Study (ARIC)–these analyses included 14,025 par-
ticipants aged 44–66 years from the prospective study that began in 1987 that was conducted
in four U.S. communities (Washington County, MD; Forsyth County, NC; Jackson, MS; and
Minneapolis, MN). Included 14,223 participants aged 44–66 years from the original cohort.
Participants were followed semi-annually with mortality follow-up to December 31, 2011 was
used.
Coronary Artery Risk Development in Young Adults (CARDIA)–these analyses included
4,989 participants aged 18–30 years from the longitudinal study that began in 1985–1986 from
Birmingham, AL; Chicago, IL; Minneapolis, MN; and Oakland, CA. Mortality follow-up to
December 31, 2011 was used.
Cardiovascular Health Study (CHS)–included 4,989 participants aged 65 and older from
the longitudinal study that was conducted in 1989–1999 from Sacramento, CA; Hagerstown,
MD; Winston-Salem, NC; and Pittsburgh, PA. Annual clinical exams were conducted with
semi-annual follow-up to assess health status for incident events and mortality adjudication.
Mortality follow-up to December 31, 2011 was used.
Multi-Ethnic Study of Atherosclerosis (MESA)–these analyses included 6,842 ethnically
diverse (White, Black, Hispanic and Asian) participants aged 44 to 84 years from the longitudi-
nal study that began in 1999. Participants were followed up every 9–12 months to ascertain
medical events. Mortality status was followed through to exam 5 (August 2015).
National Health and Nutrition Examination Survey (NHANES) III and Continuous–a
series of nationally representative cross-sectional surveys collected using a stratified, multi-
stage, probability cluster design. NHANES III was conducted between 1988 and 1994 in
33,994 individuals, ages 2 months and older. NHANES continuous cycles are released biannu-
ally 1999–2000 (n = 9,965), 2001–2 (n = 11,039), 2003–4 (n = 10,122), 2005–6 (n = 9,950),
2007–8 (n = 9,762). Of these, 6,803 participants aged 20–90 years from NHANES III and 6,748
participants aged 18–85 years from NHANES continuous are included in these analyses. Pub-
lic access Mortality Linkage data file with follow-up through December 31, 2011 was used.
Survey methods
Age, sex, ethnicity (white), self-reported medical history and medications were assessed by
questionnaire. Waist circumference was assessed by trained technicians. Mortality status was
established from associated Death Certificate Forms (DTH version), National Death Indexes
(NDI) or through follow-up exams (AFU) depending on the individual study.
The 2005 revised National Cholesterol Education Program (NCEP) metabolic syndrome
criteria was used to evaluate the association between all 32 metabolic syndrome combinations
with all-cause mortality. Metabolic syndrome was defined as having three or more of the fol-
lowing metabolic risk factors: 1) waist circumference� 102cm in men or� 88cm in women,
2) fasting serum triglyceride� 1.7mmol/L or dyslipidemia medication, 3) HDL cholesterol
< 1.03mmol/L in men or< 1.3mmol/L in women or dyslipidemia medication 4) systolic
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blood pressure (BP)� 130mmHg or diastolic BP� 85mmHg or on antihypertensive medica-
tion, 5) fasting plasma glucose� 5.6mmol/L or diabetes medication [1].
Statistical analysis
Hazards ratio (HR) with 95% confidence intervals for all-cause mortality was determined
using Cox proportional hazards regression models. Significant interaction of age and sex on
mortality was accounted for by stratifying for age (18–65 years and>65 years) and sex. Models
were adjusted for age and/or sex, white ethnicity and study cohorts. All analyses allowed ran-
dom intercepts to account for variation between study samples. Statistical analyses were per-
formed using the SAS statistical software (version 9.4; SAS Institute, Cary, NC) with a
Bonferroni adjusted significance defined at p<0.001.
Results
The proportion of participants with MetS was 32.3% in men and 34.0% in women. In younger
adults, 27.8% had MetS whereas 62.1% of older adults had MetS. Table 1 shows the character-
istics of participants stratified by sex, age and MetS status. MetS combinations are categorized
by the number of MetS risk factors present. Participant characteristics stratified by each of the
32 MetS combinations is shown in Appendix 1. Clustering of all five risk factors was the most
prevalent MetS combination present in 13.2% of men and 17.2% of women with MetS. In
men, elevated BP was the most common MetS component (49.4%) whereas elevated waist cir-
cumference (45.6%) was the most prevalent in women. The least prevalent component was ele-
vated waist circumference (26.2%) in men and elevated triglycerides (26.9%) in women. In
both younger and older adults with MetS, displaying all five metabolic factors was the most
Table 1. Characteristics of study population categorized by sex or age and MetS status.
Men Women 18–65 years (Young) >65 years (Old)
N = 82,717 With MetS Without MetS With MetS Without MetS With
MetS
Without MetS With MetS Without MetS
n (%) 16,141 (32.3) 33,815 (67.7) 11,137 (34.0) 21,624 (66.0) 19,511 (27.8) 50,702 (72.2) 7,767 (62.1) 4,737 (37.9)
Age (years) 53.9 ± 13.4 44.9 ± 13.9 60.2 ± 13.5 45.0 ± 15.5 49.9 ± 10.0 42.3 ± 12.1 73.1 ± 5.6 73.2 ± 5.9
Men (n, %) - - - - 12,718 (65.2) 31,217 (61.6) 3,423 (44.1) 2,598 (54.8)
BMI (kg/m2) 29.6 ± 4.5 25.5 ± 3.3 30.3 ± 5.9 24.4 ± 4.9 30.6 ± 5.2 25.1 ± 4.0 28.3 ± 4.5 24.9 ± 3.8
White ethnicity (n, %) 13,412 (83.1) 27,691 (81.9) 6,825 (61.3) 15,508 (71.7) 14,708 (75.4) 39,876 (78.7) 5,529 (71.2) 3,323 (70.2)
Waist (cm) 104.2 ± 11.4 90.8 ± 9.7 100.9 ± 14.0 80.4 ± 13.8 104.1 ± 12.7 86.5 ± 12.6 99.8 ± 12.0 89.8 ± 11.5
SBP (mmHg) 132 ± 17 120 ± 15 136 ± 22 115 ± 17 130 ± 18 117 ± 15 142 ± 20 132 ± 21
DBP (mmHg)� 82 ± 12 77 ± 10 73 ± 12 71 ± 10 83 ± 11 75 ± 10 72 ± 12 71 ± 12
Triglycerides (mmol/L) 2.3 ± 1.2 1.2 ± 0.7 1.9 ± 1.0 1.0 ± 0.5 2.2 ± 1.2 1.1 ± 0.6 1.8 ± 1.0 1.2 ± 0.5
HDL (mmol/L) 0.9 ± 0.3 1.3 ± 0.3 1.1 ± 0.4 1.6 ± 0.4 1.1 ± 0.3 1.4 ± 0.4 0.9 ± 0.4 1.3 ± 0.5
Glucose (mmol/L) 6.4 ± 2.0 5.4 ± 0.9 6.4 ± 2.6 5.0 ± 0.8 6.4 ± 2.3 5.2 ± 0.8 6.5 ± 2.3 5.3 ± 1.1
Follow-up Time (years) 13.0 ± 6.9 14.7 ± 7.2 13.9 ± 7.0 15.8 ± 7.8 14.4 ± 7.1 15.6 ± 7.5 11.0 ± 6.0 10.5 ± 5.8
Medication Use (n, %)† 2,652 (16.5) 1,095 (3.2) 3,398 (30.7) 848 (3.9) 1,989 (10.3) 1,043 (2.1) 4,061 (52.5) 900 (19.1)
All-cause deaths (n, %) 4,442 (27.5) 3,989 (11.8) 4,204 (37.8) 2,354 (10.9) 3,812 (19.5) 4,047 (8.0) 4,834 (62.2) 2,296 (48.5)
Data are mean ± SD or n, percent (%). MetS; metabolic syndrome, BMI; body mass index, SBP; systolic blood pressure, DBP; diastolic blood pressure, HDL; high-
density lipoprotein
�Sample size for DBP: Men: n = 43,499; Women: n = 25,108; Young: n = 56,176; Old: n = 12,431
†Sample size for medication use: Men: n = 49,820; Women n = 32,637; Young n = 69,992; Old n = 12,465
https://doi.org/10.1371/journal.pone.0218307.t001
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prevalent MetS combination (13.7%, 17.8%, respectively). Elevated BP remained the most
prevalent MetS component in both younger (41.8%) and older adults (78.8%) whereas elevated
triglyceride in younger adults (28.6%) and older adults (42.9%) was the least prevalent meta-
bolic components.
There were 14,989 (18.1%) recorded deaths in which 8,646 had MetS during the 14.6 ± 7.4
years mean follow-up period. When adjusted for age, white ethnicity, and study cohorts,
women (HR, 95% CI = 1.45, 1.38–1.54, p< 0.0001) and men (HR = 1.32, 1.26–1.38, p<
0.0001) with MetS had a higher risk for all-cause mortality when compared to individuals
without MetS. In the adjusted model, younger adults were associated with higher all-cause
mortality risk (HR = 1.55, 1.48–1.62, p< 0.0001) than older adults (HR = 1.19, 1.13–1.25, p<
0.0001). Sex- and age- specific hazards ratios of each MetS combination on all-cause mortality
are shown in Fig 1 and Fig 2, respectively.
Fig 1. Sex- specific hazards ratio (HR) for all-cause mortality categorized by number of MetS components. (A) men, (B) women. HR analyses are adjusted for age,
study, and ethnicity (white). �p< 0.001 of HR compared with zero MetS components (referent). B, blood pressure; W, waist circumference; T, triglyceride; G, glucose;
H, HDL; RF, risk factor.
https://doi.org/10.1371/journal.pone.0218307.g001
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Different combinations of MetS components varied substantially in their associations with
mortality. Significant HRs for all-cause mortality were seen in 21 of the 32 MetS combinations
in men (HR = 1.54 to 2.36, p< 0.0001) and 20 of 32 MetS combinations in women (HR = 1.43
to 2.62, p< 0.0001). Twenty-three MetS combinations in younger adults were significantly
associated with mortality (HR = 1.42 to 2.96, p< 0.001) whereas only having all 5 MetS factors
was the only combination associated with mortality in older adults (HR = 1.51, 1.23–1.87, p<
0.0001). Among the MetS combinations with significant associations, having more MetS fac-
tors generally was associated with greater HRs for all-cause mortality in men (HR = 1.15, 1.13–
1.17, p<0.0001), women (HR = 1.17, 1.15–1.20, p<0.0001), and younger adults (HR = 1.21,
1.19–1.23, p<0.0001). However, a greater number of MetS factors was less strongly related
with mortality risk in older adults (HR = 1.08, 1.06–1.11, p<0.0001).
Fig 2. Age- specific hazards ratio (HR) for all-cause mortality categorized by number of MetS components. (A) age 18–65, (B) age>65. HR analyses are adjusted for
age, sex, study, and ethnicity (white). �p< 0.001 of HR compared with zero MetS components (referent). B, blood pressure; W, waist circumference; T, triglyceride; G,
glucose; H, HDL; RF, risk factor.
https://doi.org/10.1371/journal.pone.0218307.g002
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With respects to MetS combinations, the presence of all 5 MetS risk factors in men and
women had the strongest association with mortality (Men: HR = 2.46, 2.18–2.78; Women:
HR = 2.62, 2.29–2.99, p< 0.0001). Similarly, both young and older adults with all 5 MetS fac-
tors had the strongest association with mortality (Young: HR = 2.96, 2.67–3.28, p< 0.0001;
Old: HR = 1.51, 1.23–1.87, p< 0.0001).
Elevated BP in the absence of other risk factors was significantly associated with mortality
in men (HR, 95% CI = 1.56, 1.33–1.84), women (HR = 1.62, 1.44–1.81) and younger adults
(HR = 1.61, 1.45–1.79). MetS combinations with 3 or more risk factors that included elevated
BP were more strongly associated with mortality than MetS combinations without BP in both
sex groups and younger adults. Low HDL in the absence of the other risk factors was also sig-
nificantly associated with mortality in men (HR, 95% CI = 1.56, 1.33–1.84), women
(HR = 1.40, 1.17–1.67) and younger adults (HR = 1.32, 1.15–1.53). MetS combinations with
HDL tended to be less strongly associated with mortality risk as compared to BP. Waist cir-
cumference, glucose or triglycerides in isolation were not associated with all-cause mortality in
either sex or age group.
Discussion
This study demonstrates the heterogeneity of the MetS definition and the variations in MetS
combinations in relation to all-cause mortality risk in the U.S. adult population. Results from
the analyses provide evidence that the 32 combinations of MetS vary in their associations with
mortality by age with only modest differences by sex. In particular, we observe that MetS com-
binations with elevated BP are more predictive of mortality risk than the other MetS factors in
both men and women, and younger populations, with the association between MetS and mor-
tality risk being substantively weaker in older populations.
The association between NCEP-defined MetS and all-cause mortality in the U.S. adult pop-
ulation have been well-established [11,21,22]. However, we demonstrate that risk of mortality
associated with having a greater number of metabolic risk factors was greater in younger than
older adults. In fact, older individuals showed much more modest differences in mortality
risks associated with having zero versus 5 metabolic factors (HR = 1.51 vs 2.96, respectively).
In fact, the only MetS combination that was associated with mortality risk was having all 5
MetS factors. Lower predictive value of MetS on mortality risk in older adults may be attrib-
uted to physiological decline [23] and greater risk associated with other causes of mortality
such as dementia, chronic lower respiratory diseases and pneumonia [24]. On the other hand,
MetS diagnostic criteria for BP may have underestimated the mortality risk associated with
having a high BP older adults. It has been observed that BP is more prevalent with age [25].
Age-related thickening and stiffness of arteries may have also incorrectly contribute to the
higher prevalence of BP seen in this age group [26,27]. Thus, age-specific diagnostic guideline
especially for BP may be needed to improve the predictive ability of BP in older populations.
Currently, MetS guidelines have sex-specific cut-offs for denoting elevated WC and HDL
but not glucose, BP or triglycerides. It has been previously reported that MetS is more strongly
associated with elevated mortality risk in women than men [28–30]. However, previous studies
did not examine sex differences in how each of the 32 MetS factor combinations relate with
mortality. The present large sample size allows us to extend previous observations and surpris-
ingly, although there were clear sex differences in the prevalence of certain MetS factor combi-
nations, there were only subtle sex differences in how the MetS combinations were associated
with mortality risk, with women having a subtly higher risk of mortality with MetS overall.
Thus, although we and others [9] observed sex differences in how MetS as a whole relates with
Metabolic syndrome combinations and all-cause mortality risk
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mortality, there are no specific MetS combinations that are responsible for this increased mor-
tality risk in women.
Findings also show that the components of MetS may not contribute equally to elevated
risk of all-cause mortality. Unlike clinically-defined diabetes, triglycerides, and hypertension
[31], elevated levels of WC, glucose and triglycerides in isolation failed to predict mortality
risk. That a single pre-clinically elevated risk factor in isolation is not necessarily associated
with mortality risk is in line with the concept of the metabolic syndrome, wherein a clustering
of pre-clinically elevated risk factors may be necessary for increased risk. Further research is
required to determine the optimal weighting of individual risk factors within the MetS defini-
tion in a representative population sample.
Previously, it has been observed that MetS combinations with BP as a component have the
highest estimated 10-year risk for CVD mortality using the European Society of Cardiology
(ESC) risk score [32]. Our results extend these observations and suggest the importance of ele-
vated BP alone or in combination with other MetS factors in predicting mortality regardless of
sex. Our observations suggest that BP in isolation is the only metabolic factor associated with
all-cause mortality risk and the most prominent factor seen in high risk combinations across
our study population. Although reasons behind BP as the strongest risk factor in both men
and women are still unclear, it has been suggested that elevated BP and hypertension are
directly related to the increase risk of stroke morbidity [33], and CVD deaths [34] which are
leading causes of death in the U.S. [35]. Thus, we propose that greater emphasis should be
given to the diagnosis and treatment of BP, particularly in younger populations.
There are strengths and limitations of this study that merit discussion. This study was the
first to our knowledge to examine mortality risk associated with each of the 32 MetS combina-
tions in both men and women as well as in younger and older adults. Due to our merged sam-
ple of several cohorts, there may have been variations in reporting of questionnaire data or
assessment of physiological and lifestyle factors in our sample that was not entirely accounted
for by our statistical adjustment and this may have influenced our findings. Ethnic variations
were not examined as our sample was predominately of white ethnicity. Finally, our study pop-
ulation is not nationally representative sample of the U.S. and thus, do not allow for accurate
determination of prevalence rates on metabolic combinations and the populations attributable
risk for each of these MetS combinations.
Conclusions
In a large-scale U.S. sample, the present study provides evidence that MetS is a heterogeneous
syndrome wherein the expressions of different metabolic risk factor combinations show sub-
stantial variations in its associations with all-cause mortality by age and modestly by sex.
Regardless of sex, individuals with elevated BP in isolation or in a combination with other met-
abolic factors also had greater mortality risk. Thus, we suggest that the metabolic factors within
the MetS definition may warrant age- and risk factor-specific weightings to better account for
the differences in predictive value of the metabolic risk factors in different age groups.
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